Genedata

Executive Summary

Genedata, headquartered in Basel, Switzerland, is a private enterprise software company that has been a key enabler in biopharmaceutical R&D since 1997. Its platform automates complex workflows across biologics, small molecules, and novel modalities, integrating data and embedding AI to accelerate drug discovery and development. Serving as a digital backbone for leading biopharma organizations, Genedata enables data-driven decision-making, reducing time and cost in bringing therapies to market. The company's focus on automation and AI positions it well in an industry increasingly reliant on digital transformation. With a strong foothold in Europe and growing global presence, Genedata is poised to benefit from the expanding need for integrated R&D software solutions across the pharmaceutical value chain.

Upcoming Catalysts (preview)

• Q3 2026Launch of next-generation AI-driven platform for predictive modeling in drug discovery75% success
• Q4 2026Major partnership with top-20 pharma company for enterprise-wide deployment60% success
• Q1 2027Expansion of platform capabilities into cell and gene therapy workflow automation80% success